KORU Medical Systems, Inc.
KRMDNASDAQHealthcare● Active
$4.00
+$0.07(+1.65%)
Market Cap$183502335
P/E Ratio—
52W High$6.608
52W Low$2.77
KORU Medical Systems, Inc. (KRMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
KRMD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.02
Est. -$0.02 · +0.0%
Revenue
$0.01B
Est. $0.01B · +4.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
KRMD reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.02 | — | — | — | $0.01B | — |
| — Q2 FY2026 | May 6, 2026 | -$0.02 | -$0.02 | +0.0% | $0.01B | $0.01B | +4.3% |
| ▲ Q1 FY2026 | Mar 12, 2026 | -$0.02 | -$0.01 | +50.0% | $0.01B | $0.01B | +0.7% |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$0.03 | -$0.02 | +33.3% | $0.01B | $0.01B | -4.6% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.03 | $0.01 | +133.3% | $0.01B | $0.01B | +5.5% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.02 | -$0.03 | -50.0% | $0.01B | $0.01B | +1.9% |
| — Q1 FY2025 | Mar 12, 2025 | -$0.03 | -$0.03 | +0.0% | $0.01B | $0.01B | -0.3% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.02 | -$0.03 | -21.1% | $0.01B | $0.01B | +0.6% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
+0.0%
Revenue
$0.01B
Q1 FY2026
Mar 12, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+50.0%
Revenue
$0.01B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.03
EPS Surpr.
+33.3%
Revenue
$0.01B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.03
EPS Surpr.
+133.3%
Revenue
$0.01B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.03
EPS Est.
-$0.02
EPS Surpr.
-50.0%
Revenue
$0.01B
Q1 FY2025
Mar 12, 2025
EPS Actual
-$0.03
EPS Est.
-$0.03
EPS Surpr.
+0.0%
Revenue
$0.01B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$0.03
EPS Est.
-$0.02
EPS Surpr.
-21.1%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.04 | $0.04 | $0.04 | 1 |
| Q3 FY2028 | $0.03 | $0.03 | $0.03 | 1 |
| Q2 FY2028 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2028 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2027 | $0.02 | $0.03 | $0.03 | 1 |
| Q3 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +0.0% | $4.08 | $4.01 | -1.72% |
| ▲ Q1 FY2026 | Mar 12, 2026 | +50.0% | $4.51 | $4.31 | -4.43% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +33.3% | $3.73 | $3.78 | +1.34% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +133.3% | $3.28 | $3.26 | -0.61% |
| ▼ Q2 FY2025 | May 7, 2025 | -50.0% | $2.74 | $2.72 | -0.73% |
| ▲ Q1 FY2025 | Mar 12, 2025 | +0.0% | $3.11 | $3.28 | +5.47% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -21.1% | $2.97 | $3.20 | +7.74% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -52.3% | $2.24 | $2.13 | -4.91% |
Q2 FY2026-1.72%
Report Date
May 6, 2026
EPS Beat/Miss
+0.0%
Price Before
$4.08
Price After
$4.01
Q1 FY2026-4.43%
Report Date
Mar 12, 2026
EPS Beat/Miss
+50.0%
Price Before
$4.51
Price After
$4.31
Q4 FY2025+1.34%
Report Date
Nov 12, 2025
EPS Beat/Miss
+33.3%
Price Before
$3.73
Price After
$3.78
Q3 FY2025-0.61%
Report Date
Aug 6, 2025
EPS Beat/Miss
+133.3%
Price Before
$3.28
Price After
$3.26
Q2 FY2025-0.73%
Report Date
May 7, 2025
EPS Beat/Miss
-50.0%
Price Before
$2.74
Price After
$2.72
Q1 FY2025+5.47%
Report Date
Mar 12, 2025
EPS Beat/Miss
+0.0%
Price Before
$3.11
Price After
$3.28
Q4 FY2024+7.74%
Report Date
Nov 13, 2024
EPS Beat/Miss
-21.1%
Price Before
$2.97
Price After
$3.20
Q3 FY2024-4.91%
Report Date
Aug 7, 2024
EPS Beat/Miss
-52.3%
Price Before
$2.24
Price After
$2.13
Avg Beat Reaction+0.01%
Avg Miss Reaction+0.70%
Beat Rate5 / 8 quarters
Largest Move+7.74% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: KRMD ends December
KORU Medical Systems, Inc. (KRMD) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.02 (in line with the analyst consensus of $-0.02). KRMD has beaten EPS estimates for 4 consecutive quarters. The next KRMD earnings date is expected around September 1, 2026.
Each quarter, investors track KRMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KRMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
KRMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
KRMD earnings · 4 questionsKORU Medical Systems, Inc.'s next earnings report is expected around September 1, 2026. KRMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KRMD historically reports after market close (AMC).
KRMD earnings datewhen is KRMD earningsKRMD next earnings datewhen does KRMD report earningsKRMD earnings calendar
▸ Source: FMP · KORU Medical Systems, Inc. SEC filings · US GAAP · KORU Medical Systems, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026